Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jillian E. Koziel
The Telomerase Inhibitor Imetelstat Alone, and in Combination With Trastuzumab, Decreases the Cancer Stem Cell Population and Self-Renewal of HER2+ Breast Cancer Cells
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population
Molecular Cell
Cell Biology
Molecular Biology
Trastuzumab in Combination With AT-101 Induces Cytotoxicity and Apoptosis in Her2 Positive Breast Cancer Cells
Future Oncology
Medicine
Cancer Research
Oncology
Telomerase and Cancer Stem Cells
Cold Spring Harbor Symposia on Quantitative Biology
Biochemistry
Genetics
Molecular Biology
HER2 and Breast Cancer Stem Cells: More Than Meets the Eye
Cancer Research
Cancer Research
Oncology
The Combination of NVP-BKM120 With Trastuzumab or RAD001 Synergistically Inhibits the Growth of Breast Cancer Stem Cells in Vivo
Oncology Reports
Medicine
Cancer Research
Oncology
Breast Cancer Stem Cells in HER2-negative Breast Cancer Cells Contribute to HER2-mediated Radioresistance and Molecular Subtype Conversion: Clinical Implications for Serum HER2 in Recurrent HER2-negative Breast Cancer
Oncotarget
Oncology
WNT Signaling Regulates Self-Renewal and Differentiation of Prostate Cancer Cells With Stem Cell Characteristics
Cell Research
Cell Biology
Molecular Biology
Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
A Self-Renewal Assay for Cancer Stem Cells
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
